These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 37295840)
1. Facilitators and barriers for vaccination in patients with inflammatory rheumatic musculoskeletal diseases: a prospective cohort study. Andreica I; Roman I; Redeker I; Baraliakos X; Braun J; Kiltz U RMD Open; 2023 Jun; 9(2):. PubMed ID: 37295840 [TBL] [Abstract][Full Text] [Related]
2. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry. Machado PM; Lawson-Tovey S; Strangfeld A; Mateus EF; Hyrich KL; Gossec L; Carmona L; Rodrigues A; Raffeiner B; Duarte C; Hachulla E; Veillard E; Strakova E; Burmester GR; Yardımcı GK; Gomez-Puerta JA; Zepa J; Kearsley-Fleet L; Trefond L; Cunha M; Mosca M; Cornalba M; Soubrier M; Roux N; Brocq O; Durez P; Conway R; Goulenok T; Bijlsma JW; McInnes IB; Mariette X Ann Rheum Dis; 2022 May; 81(5):695-709. PubMed ID: 34972811 [TBL] [Abstract][Full Text] [Related]
3. Barriers and facilitators to vaccination uptake against COVID-19, influenza, and pneumococcal pneumonia in immunosuppressed adults with immune-mediated inflammatory diseases: A qualitative interview study during the COVID-19 pandemic. Fuller A; Hancox J; Vedhara K; Card T; Mallen C; Van-Tam JSN; Abhishek A PLoS One; 2022; 17(9):e0267769. PubMed ID: 36084032 [TBL] [Abstract][Full Text] [Related]
4. First SARS-CoV-2 vaccine booster and influenza vaccination: risk assessment of COVID-19 hospitalisation and death. Russo AG; Faccini M; Decarli A; Cattaneo S; Tunesi S; Murtas R; Fagandini F; Bergamaschi W Epidemiol Prev; 2022; 46(5-6):324-332. PubMed ID: 36341584 [TBL] [Abstract][Full Text] [Related]
5. Facilitators and barriers to vaccination uptake in pregnancy: A qualitative systematic review. Razai MS; Mansour R; Ravindran P; Freeman S; Mason-Apps C; Morris J; Majeed A; Ussher M; Hargreaves S; Oakeshott P PLoS One; 2024; 19(4):e0298407. PubMed ID: 38640190 [TBL] [Abstract][Full Text] [Related]
6. Barriers and facilitators of vaccine hesitancy for COVID-19, influenza, and pertussis during pregnancy and in mothers of infants under two years: An umbrella review. Nichol B; McCready JL; Steen M; Unsworth J; Simonetti V; Tomietto M PLoS One; 2023; 18(3):e0282525. PubMed ID: 36862698 [TBL] [Abstract][Full Text] [Related]
7. Long-term Behavioral Changes During the COVID-19 Pandemic and Impact of Vaccination in Patients With Inflammatory Rheumatic Diseases. Glintborg B; Jensen DV; Terslev L; Hendricks O; Østergaard M; Rasmussen SH; Jensen MP; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Sørensen CM; Krogh NS; Agerbo JN; Ziegler C; Hetland ML J Rheumatol; 2022 Oct; 49(10):1163-1172. PubMed ID: 35705237 [TBL] [Abstract][Full Text] [Related]
8. SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study. Ko T; Dendle C; Woolley I; Morand E; Antony A Hum Vaccin Immunother; 2021 Nov; 17(11):4048-4056. PubMed ID: 34357827 [TBL] [Abstract][Full Text] [Related]
9. A social ecological approach to identify the barriers and facilitators to COVID-19 vaccination acceptance: A scoping review. Lun P; Gao J; Tang B; Yu CC; Jabbar KA; Low JA; George PP PLoS One; 2022; 17(10):e0272642. PubMed ID: 36191018 [TBL] [Abstract][Full Text] [Related]
10. The COVID-19 and Influenza "Twindemic": Barriers to Influenza Vaccination and Potential Acceptance of SARS-CoV2 Vaccination in African Americans. Ferdinand KC; Nedunchezhian S; Reddy TK J Natl Med Assoc; 2020 Dec; 112(6):681-687. PubMed ID: 33276969 [TBL] [Abstract][Full Text] [Related]
11. Determinants of SARS-CoV-2 vaccine willingness among people incarcerated in 3 Canadian federal prisons: a cross-sectional study. Romanchuk K; Linthwaite B; Cox J; Park H; Dussault C; Basta NE; Varsaneux O; Worthington J; Lebouché B; MacDonald SE; Ismail SJ; Kronfli N CMAJ Open; 2022; 10(4):E922-E929. PubMed ID: 36280247 [TBL] [Abstract][Full Text] [Related]
12. Determinants of Influenza Vaccine Uptake in Patients With Cardiovascular Disease and Strategies for Improvement. Bhugra P; Grandhi GR; Mszar R; Satish P; Singh R; Blaha M; Blankstein R; Virani SS; Cainzos-Achirica M; Nasir K J Am Heart Assoc; 2021 Aug; 10(15):e019671. PubMed ID: 34315229 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of inactivated SARS-CoV-2 vaccination in COVID-19-associated pneumonia among patients with rheumatic and musculoskeletal diseases: A real-world retrospective observational study. Liu S; Jin Z; Feng X; Da Z; Tang Y; Hu H; Wang D; Sun L Int J Rheum Dis; 2024 May; 27(5):e15166. PubMed ID: 38720417 [TBL] [Abstract][Full Text] [Related]
14. Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations. Kroon FPB; Najm A; Alunno A; Schoones JW; Landewé RBM; Machado PM; Navarro-Compán V Ann Rheum Dis; 2022 Mar; 81(3):422-432. PubMed ID: 34876462 [TBL] [Abstract][Full Text] [Related]
15. Parents' intent to vaccinate against influenza during the COVID-19 pandemic in two regions in Switzerland. Seiler M; Goldman RD; Staubli G; Hoeffe J; Gualco G; Manzano S; Part Of The International Covid-Parental Attitude Study Covipas Group Swiss Med Wkly; 2021 May; 151():w20508. PubMed ID: 34002802 [TBL] [Abstract][Full Text] [Related]
16. Knowledge, barriers and facilitators regarding COVID-19 vaccine and vaccination programme among the general population: A cross-sectional survey from one thousand two hundred and forty-nine participants. Kumari A; Ranjan P; Chopra S; Kaur D; Kaur T; Upadhyay AD; Isaac JA; Kasiraj R; Prakash B; Kumar P; Dwivedi SN; Vikram NK Diabetes Metab Syndr; 2021; 15(3):987-992. PubMed ID: 33984818 [TBL] [Abstract][Full Text] [Related]
17. Association of Influenza Vaccination With SARS-CoV-2 Infection and Associated Hospitalization and Mortality Among Patients Aged 66 Years or Older. Hosseini-Moghaddam SM; He S; Calzavara A; Campitelli MA; Kwong JC JAMA Netw Open; 2022 Sep; 5(9):e2233730. PubMed ID: 36169955 [TBL] [Abstract][Full Text] [Related]
18. Perceived Risk of SARS-CoV-2 at the Start of the COVID-19 Pandemic and Subsequent Vaccination Attitudes in Patients With Rheumatic Diseases: A Longitudinal Analysis. Duculan R; Mancuso CA J Clin Rheumatol; 2022 Jun; 28(4):190-195. PubMed ID: 35067512 [TBL] [Abstract][Full Text] [Related]
19. Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases. Felten R; Dubois M; Ugarte-Gil MF; Chaudier A; Kawka L; Bergier H; Costecalde C; Pijnenburg L; Fort J; Chatelus E; Sordet C; Javier RM; Gottenberg JE; Sibilia J; Fuentes-Silva YJ; Arnaud L Rheumatology (Oxford); 2021 Oct; 60(SI):SI68-SI76. PubMed ID: 33983432 [TBL] [Abstract][Full Text] [Related]
20. Social Attitude to COVID-19 and Influenza Vaccinations after the Influenza Vaccination Season and between the Second and Third COVID-19 Wave in Poland, Lithuania, and Ukraine. Zaprutko T; Kremin Y; Michalak M; Bernatoniene J; Zaprutko L; Hudz N; Stolecka A; Cynar J; Niewczas K; Sprawka J; Skorupska P; Wróbel J; Ratajczak P; Kopciuch D; Paczkowska A; Kus K; Hromovyk B Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]